Related Experiment Video

Updated: Aug 9, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

[Intercellular adhesion molecule 1 antigen in tuberculosis]

N Shijubo1, M Hirasawa, M Inuzuka

  • 1Third Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.

Kekkaku : [Tuberculosis]
|July 1, 1994
PubMed

Insights

Intercellular adhesion molecule 1 (ICAM-1) is elevated in patients with miliary and severe pulmonary tuberculosis. This adhesion molecule is significantly present in lung tissues, suggesting its role in tuberculosis pathogenesis.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cell Biology

Context:

  • Intercellular adhesion molecule 1 (ICAM-1) is implicated in inflammatory processes.
  • Tuberculosis remains a significant global health challenge, necessitating research into its underlying mechanisms.

Purpose:

  • To investigate circulating soluble ICAM-1 levels in patients with miliary and pulmonary tuberculosis.
  • To correlate ICAM-1 levels with tuberculosis severity based on chest X-ray classification.
  • To examine the expression of ICAM-1 in tuberculous lung tissues.

Summary:

  • Significantly higher soluble ICAM-1 levels were observed in patients with miliary tuberculosis and extensive (extent 3) pulmonary tuberculosis compared to controls.
  • No significant difference in ICAM-1 levels was found in patients with extent 1 or 2 pulmonary tuberculosis.
  • Immunohistochemical analysis revealed intense ICAM-1 expression on epithelioid cells, giant cells, and vascular endothelial cells in tuberculous lung tissues.

Impact:

  • These findings highlight ICAM-1 as a potential biomarker for tuberculosis severity.
  • The results suggest ICAM-1 plays a crucial role in the inflammatory response and pathogenesis of tuberculosis.
  • Understanding ICAM-1's role may open avenues for novel therapeutic strategies in tuberculosis treatment.

More Related Videos

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis06:14

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis

Published on: September 26, 2025

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF107:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...